Howard Hughes Medical Institute’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-534
Closed -$56.2K 325
2025
Q4
$56.2K Sell
534
-3
-0.6% -$282 0.03% 38
2025
Q3
$45.1K Sell
537
-9
-2% -$741 0.03% 42
2025
Q2
$43.2K Buy
+546
New +$43.4K 0.02% 44

Other funds holding MRK

Howard Hughes Medical Institute's MRK Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Merck (MRK) in Q1 2026, closing a stake of 534 shares — an estimated $56.2K sold.

Howard Hughes Medical Institute first reported a position in MRK in Q2 2025 and held it in 3 quarters. The position peaked at $56.2K in Q4 2025. 3,784 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 534 Merck shares in Q1 2026, an estimated $56.2K.
  • Howard Hughes Medical Institute first reported a position in Merck in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Merck position peaked at $56.2K in Q4 2025.
  • 3,784 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.